Clinical Research Directory

Inclusion Criteria: * At least 18 years of age * Diagnosed with testicular cancer (any type, stage, or risk category) without evidence of active distant disease at time of study entry * Completed surgery, chemotherapy, radiation therapy, and/or stem cell transplant 5 years or less prior to enrollment * Willing to provide authorization to be contacted by email * Willing to complete surveys * Willing to participate in six, 90-minute intervention sessions * Able to speak and read English * Has clinically significant fear of cancer recurrence (FCR-4 score = 9 or higher) and/or anxiety (GAD-2 score = 3 or higher) at eligibility screening Exclusion Criteria: * Completed surgery, chemotherapy, radiation therapy, and/or stem cell transplant less than 2 weeks prior to enrollment (excluding to avoid acute toxicity side effects of treatment) * Patient has co-morbidities or deficits that would impair participation in the study, including: 1. history of neurological disorder or traumatic brain injury (e.g., stroke, encephalitis, epilepsy, loss of consciousness greater than 10 minutes); 2. severe depressive symptoms (PHQ-2 score = 5 or higher at screening), 3. active substance abuse or uncontrolled bipolar disorder, schizophrenia, or psychosis; 4. obvious hearing and/or communicative disability that would impair their participation * Patient is currently participating in "The Platinum Study" (PI: Lois Travis) * Currently participating in psychotherapy focused on cancer-specific adjustment/support * Currently participating in any behavioral/psychosocial research study that has the potential to skew results of this study or the study in which the survivor is participating